GlaxoSmithKline Pharmaceuticals Limited has disclosed that the Directorate of Revenue Intelligence (DRI), Department of Revenue, Government of India, initiated a search at the company's registered office in Mumbai. The search was conducted from 27th February 2026 to 28th February 2026, pursuant to Section 105 of the Customs Act, 1962. The company stated that its business operations continue as usual, and officials extended full cooperation to the DRI, responding to all queries. The announcement specifies that there has been no impact on the financial, operational, or other activities of the company, quantifiable in monetary terms. The disclosure was made on 28th February 2026, in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
